Catalyst Wire Dossier Catalyst Wire Dossier

Firategrast (SB683699)

Firategrast · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Firategrast (SB683699), covering 2017-08-01 to 2017-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients [Phase 1]

See pricing